Senior Biostatistician

Organization
GRAIL, Inc.
Job Location
Redwood City, CA
Job Description

The Senior Biostatistician provides statistical expertise and statistical solutions to clinical projects, including the design and analysis of the clinical development and validation studies in support of GRAIL products. 

  • Participate and contribute to clinical strategies for GRAIL product development.
  • Collaborate with internal and external thought leaders in the design, analysis, interpretation, and publication of clinical studies.
  • Contribute to protocols, statistical analysis plans, study reports, presentations, and publications of clinical studies.
  • Serve as a member of clinical study teams.
  • Stay abreast of industry and academic developments in the Statistical Genomics field and apply to clinical study design and analysis.
Requirements

PREFERRED BACKGROUND

  • 5+ years of experience in academia or industry. Molecular diagnostics industry experience preferred.
  • PhD in Biostatistics or equivalent.
  • Strong knowledge of theoretical and applied statistics.
  • Knowledge of applicable regulatory rules and guidelines, e.g., ICH, GCP, HIPAA.
  • Experience programing in SAS or R.
  • Strong team player with demonstrated track record of success in cross­-functional team environment. 
About Our Organization

GRAIL, Inc. is developing paradigm­-changing clinical assays for early cancer detection, based on unique biological insights from high-­intensity sequencing analysis of circulating cell­-free nucleic acids. We are seeking passionate and talented individuals to join us in realizing our mission, which has the potential to dramatically reduce the global burden of cancer.

A part of the proposed tax bill in the US could make tuition waivers taxable, Vox reports.

The New York Times reports that only a subset of STEM worker are in demand.

US News & World Report says students pursuing STEM degrees should consider what they are getting into.

New study finds bias against female lecturers among student course evaluations, the Economist reports.